drugset / Trial / NCT02453490

Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis

NCT02453490

Phase 3 Terminated 360 enrolled Zhejiang University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a multicenter ,randomization, open control study to evaluate the efficacy and safety of Raltitrexed-based chemotherapy and 5-fluorouracil-based chemotherapy in the peri-operative treatment of patients with Liver Metastasis From colorectal cancer (CRC).

Timeline

Start
2015-10-11
Primary completion
2018-09-11
Completion
2019-09-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Irinotecan Small molecule 180 mg/m2 Intravenous
Comparator Oxaliplatin Small molecule 85 mg/m2 Intravenous
Subject Raltitrexed Small molecule 2 mg Intravenous
Comparator fluorouracil Small molecule 1200 mg/m2 Intravenous